Tomas Kazda Selected Research

Tomas Kazda Research Topics

Disease

13	Neoplasms (Cancer) 03/2022 - 01/2015
6	Brain Neoplasms (Brain Tumor) 03/2022 - 06/2014
6	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 01/2015
5	Head and Neck Neoplasms (Head and Neck Cancer) 03/2021 - 01/2019
4	Squamous Cell Carcinoma of Head and Neck 06/2020 - 10/2018
2	Pain (Aches) 03/2021 - 12/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Radiation Injuries (Radiation Sickness) 01/2018 - 10/2015
2	Giant Cell Arteritis (Horton Disease) 08/2017 - 03/2017
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 08/2017 - 03/2017
1	Adenocarcinoma 12/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Nonseminomatous germ cell tumor 06/2021
1	Glomerulonephritis 06/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 06/2021
1	Testicular Neoplasms (Testicular Cancer) 06/2021
1	Chronic Renal Insufficiency 06/2021
1	Triple Negative Breast Neoplasms 03/2021
1	Breast Neoplasms (Breast Cancer) 03/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 03/2021
1	Genomic Instability 01/2021
1	Nausea 12/2020
1	Acute Pain 12/2020
1	Xerostomia 12/2020
1	COVID-19 11/2020
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 11/2020
1	Drug-Related Side Effects and Adverse Reactions 10/2020
1	Kidney Neoplasms (Kidney Cancer) 10/2020
1	Lymphedema (Milroy Disease) 10/2020
1	AIDS-Related Complex (ARC) 01/2020
1	Carcinoma (Carcinomatosis) 03/2019
1	Glioma (Gliomas) 04/2018
1	Cognitive Dysfunction 12/2017
1	Tenosynovitis 03/2017
1	Prostatic Neoplasms (Prostate Cancer) 09/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Carcinogenesis 01/2016

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 06/2020 - 01/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2019
3	MicroRNAs (MicroRNA)IBA 06/2020 - 03/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2017 - 03/2017
2	Protons (Proton)IBA 10/2015 - 01/2015
1	HLA-G Antigens (HLA G)IBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2021
1	alectinibIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	CrizotinibIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 06/2021
1	PlatinumIBA 03/2021
1	SaltsIBA 03/2021
1	Analgesics (Analgesic Drugs)IBA 03/2021
1	Piwi-Interacting RNAIBA 01/2021
1	antineoplaston A10 (A 10)IBA 12/2020
1	Everolimus FDA Link 10/2020
1	TOR Serine-Threonine KinasesIBA 10/2020
1	thiamine triphosphorate (TTP)IBA 01/2020
1	Amino Acids FDA Link 04/2018
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2018
1	Dihydroxyphenylalanine (Dopa)IBA 04/2018
1	Biological ProductsIBA 04/2018
1	Choline (Choline Chloride)IBA 01/2016
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	Panitumumab (Vectibix)FDA Link 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 01/2015

Therapy/Procedure

19	Radiotherapy 12/2021 - 06/2014
6	Therapeutics 03/2022 - 01/2015
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2020 - 03/2019
2	Drug Therapy (Chemotherapy) 12/2021 - 10/2021
2	Kidney Transplantation 10/2021 - 06/2021
2	Retreatment 11/2020 - 10/2020
1	Chemoradiotherapy 12/2021
1	Orchiectomy (Orchidectomy) 06/2021
1	Adjuvant Chemotherapy 06/2021
1	Neoadjuvant Therapy 03/2021
1	Surgical Amputation (Amputations) 03/2021
1	Pain Management 03/2021
1	Re-Irradiation 01/2021
1	Adjuvant Radiotherapy 06/2018
1	Immunotherapy 06/2018
1	Aftercare (After-Treatment) 01/2015